TSLA · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $94.83B | $97.69B | $96.77B | $81.46B | $53.82B | $31.54B | $24.58B | $21.46B |
| Cost of Revenue | $77.73B | $80.24B | $79.11B | $60.61B | $40.22B | $24.91B | $20.51B | $17.42B |
| Gross Profit | $17.09B | $17.45B | $17.66B | $20.85B | $13.61B | $6.63B | $4.07B | $4.04B |
| Research & Development | $6.41B | $4.54B | $3.97B | $3.08B | $2.59B | $1.49B | $1.34B | $1.46B |
| Selling, General & Administrative | $5.83B | $5.15B | $4.80B | $3.95B | $4.52B | $3.15B | $2.65B | $2.83B |
| Operating Expenses | $12.74B | $10.37B | $8.77B | $7.20B | $7.08B | $4.64B | $4.14B | $4.43B |
| Operating Income | $4.36B | $7.08B | $8.89B | $13.66B | $6.52B | $1.99B | -$69.00M | -$388.00M |
| Interest Expense | — | — | $156.00M | $191.00M | $371.00M | $748.00M | $685.00M | $663.00M |
| Other Income / (Expense) | -$419.00M | $695.00M | $172.00M | -$43.00M | $135.00M | -$122.00M | $45.00M | $22.00M |
| Income Before Taxes | $5.28B | $8.99B | $9.97B | $13.72B | $6.34B | $1.15B | -$665.00M | -$1.00B |
| Provision for Income Taxes | $1.42B | $1.84B | -$5.00B | $1.13B | $699.00M | $292.00M | $110.00M | $58.00M |
| Net Income | $3.79B | $7.09B | $15.00B | $12.56B | $5.52B | $721.00M | -$862.00M | -$976.00M |
| Basic EPS | $1.18 | $2.23 | $4.73 | $4.02 | $1.87 | $0.25 | -$0.98 | -$1.14 |
| Diluted EPS | $1.08 | $2.04 | $4.30 | $3.62 | $1.63 | $0.21 | -$0.98 | -$1.14 |
| Basic Shares Outstanding | 3.23B | 3.20B | 3.17B | 3.13B | 2.96B | 2.80B | 887.00M | 853.00M |
| Diluted Shares Outstanding | 3.53B | 3.50B | 3.48B | 3.48B | 3.39B | 3.25B | 887.00M | 853.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $0.89 | $0.48 | $1.47 | 15 | ↑3 ↓8 |
| Dec 2027 | $1.38 | $0.40 | $2.96 | 15 | ↑1 ↓8 |
| Dec 2028 | $1.21 | $0.01 | $1.83 | 5 | ↑0 ↓0 |
